SEARCH

SEARCH BY CITATION

References

  • Alakurtti K, Weber E, Rinne R, Theil G, De Haan GJ, Lindhout D, Salmikangas P, Saukko P, Lahtinen U, Lehesjoki AE. (2005) Loss of lysosomal association of cystatin B proteins representing progressive myoclonus epilepsy, EPM1, mutations. Eur J Hum Genet 13:208215.
  • Barton-Davis ER, Cordier L, Shoturma DI, Leland SE, Sweeney HL. (1999) Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice. J Clin Invest 104:375381.
  • Baulac S, Gourfinkel-An I, Picard F, Rosenberg-Bourgin M, Prud-homme JF, Baulac M, Brice A, LeGuern E. (1999) A second locus for familial generalized epilepsy with febrile seizures plus maps to chromosome 2q21-q33. Am J Hum Genet 65:10781085.
  • Baulac S, Huberfeld G, Gourfinkel-An I, Mitropoulou G, Beranger A, Prud’Homme J-F, Baulac M, Brice A, Bruzzone R, LeGuern E. (2001) First genetic evidence of GABAA receptor dysfunction in epilepsy: A mutation in the {gamma}2-subunit gene. Nat Genet 28:4648.
  • Berkovic SF, Harkin L, McMahon JM, Pelekanos JT, Zuberi SM, Wirrell EC, Gill DS, Iona X, Mulley JC, Scheffer IE. (2006) De-novo mutations of the sodium channel gene SCN1A in alleged vaccine encephalopathy: A retrospective study. Lancet Neurol 5:488492.
  • Biraben A, Allain H, Scarabin JM, Schück S, Edan G. (2000) Exacerbation of juvenile myoclonic epilepsy with lamotrigine. Neurology 55:1758.
  • Brooks DA, Muller VJ, Hopwood JJ. (2006) Stop-codon read-through for patients affected by a lysosomal storage disorder. Trends Mol Med 12:367373.
  • Carrazana EJ, Wheeler SD. (2001) Exacerbation of juvenile myoclonic epilepsy with lamotrigine. Neurology 56:14241425.
  • Ceulemans B, Boel M, Claes L, Dom L, Willekens H, Thiry P, Lagae L. (2004) Severe myoclonic epilepsy in infancy: toward an optimal treatment. Child Neurol 19:516521.
  • Claes L, Del-Favero J, Ceulemans B, Lagae L, Van Broeckhoven C, De Jonghe P. (2001) De Novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 68:13271332.
  • Clancy JP, Bebök Z, Ruiz F, King C, Jones J, Walker L, Greer H, Hong J, Wing L, Macaluso M, Lyrene R, Sorscher EJ, Bedwell DM. (2001) Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis. Am J Respir Crit Care Med 1963:16831692.
  • Colosimo E, Gambardella A, Mantegazza M, Labate A, Rusconi R, Schiavon E, Annesi F, Cassulini RR, Carrideo S, Chifari R, Canevini MP, Canger R, Franceschetti S, Annesi G, Wanke E, Quattrone A. (2007) Electroclinical features of a family with simple febrile seizures and temporal lobe epilepsy associated with SCN1A loss-of-function mutation. Epilepsia 48:16911696.
  • Cossette P, Liu L, Brisebois K, Dong H, Lortie A, Vanasse M, Saint-Hilaire JM, Carmant L, Verner A, Lu WY, Wang YT, Rouleau GA. (2002) Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy. Nat Genet 31:184189.
  • Delgado-Escueta AV. (2007a) Advances in Lafora progressive myoclonus epilepsy. Curr Neurol Neurosci Rep 7/5:428433.
  • Delgado-Escueta AV. (2007b) Advances in genetics of juvenile myoclonic epilepsies. Epilepsy Curr 7:6167.
  • Dibbens LM, Feng HJ, Richards MC, Harkin LA, Hodgson BL, Scott D, Jenkins M, Petrou S, Sutherland GR, Scheffer IE, Berkovic SF, Macdonald RL, Mulley JC. (2004) GABRD encoding a protein for extra- or peri-synaptic GABAA receptors is a susceptibility locus for generalized epilepsies. Hum Mol Genet 13:13151319.
  • Dravet C, Bureau M, Guerrini R et al. (1992). Severe myoclonic epilepsy in infants. In RogerJ, DravetC, BureauM, DreifussFE, PerretA, WolfP (Eds) Epileptic syndromes in infancy, childhood and adolescence. 2nd ed. John Libbey, London, pp. 7588.
  • Dravet C, Bureau M, Oguni H, Fukuyama Y, Cokar O. (2005) Severe myoclonic epilepsy in infancy: Dravet syndrome. Adv Neurol 95:71102.
  • Dravet C, Bureau M, Oguni H, Fukuyama Y, Cokar O. (2006) Severe myoclonic epilepsy in infancy. In RogerJ, BureauM, DravetC, GentonP, TassinariCA, WolfP (Eds) Epileptic syndromes in infancy, childhood and adolescence. 4th ed. John Libbey Eurotext, France, pp. 89113.
  • Ebach K, Joos H, Doose H, Stephani U, Kurlemann G, Fiedler B, Hahn A, Hauser E, Hundt K, Holthausen H, Müller U, Neubauer BA. (2005) SCN1A mutation analysis in myoclonic astatic epilepsy and severe idiopathic generalized epilepsy of infancy with generalized tonic-clonic seizures. Neuropediatrics 36:210213.
  • Edwards MJ, Hargreaves IP, Heales SJ, Jones SJ, Ramachandran V, Bhatia KP, Sisodiya S. (2002) N-acetylcysteine and Unverricht-Lundborg disease: variable response and possible side effects. Neurology 59:14471449.
  • Eldridge R, Iivanainen M, Stern R, Koerber I, Wilder BJ. (1983) ‘Baltic’ myoclonus epilepsy: hereditary disorder of childhood made worse by phenytoin. Lancet ii:838842.
  • Escayg A, MacDonald BT, Meisler MH, Baulac S, Huberfeld G, An-Gourfinkel I, Brice A, LeGuern E, Moulard B, Chaigne D, Buresi C, Malafosse A. (2000) Mutations of SCN1A, encoding a neuronal sodium channel in two families with GEFS+2. Nat Genet 24:343345.
  • Escayg A, Heils A, MacDonald BT, Haug K, Sander T, Meisler MH. (2001) A novel SCN1A mutation associated with generalized epilepsy with febrile seizures plus – and prevalence of variants in patients with epilepsy. Am J Hum Genet 68:866873.
  • Ferraro TN, Dlugos DJ, Buono RJ. (2006) Role of genetics in the diagnosis and treatment of epilepsy. Expert Rev Neurother 6:17891800.
  • Fujiwara T. (2006) Clinical spectrum of mutations in SCN1A gene: Severe myoclonic epilepsy in infancy and related epilepsies. Epilepsy Res 70(Suppl 1):223230.
  • Fujiwara T, Sugawara T, Mazaki-Miyazaki E, Takahashi Y, Fukushima K, Watanabe M, Hara K, Morikawa T, Yagi K, Yamakawa K, Inoue Y. (2003) Mutations of sodium channel a subunit type 1 (SCN1A) in intractable childhood epilepsies with frequent generalized tonic clonic seizures. Brain 126:531546.
  • Ganesh S, Delgado-Escueta AV, Suzuki T, Francheschetti S, Riggio C, Avanzini G, Rabinowicz A, Thomson A, Bohlega S, Bailey J, Alonso ME, Rasmussen A, Ochoa A, Jara-Prado A, Medina MT, Yamakawa K. (2002) Genotype-phenotype correlations for EPM2A mutations in Lafora’s progressive myoclonus epilepsy: exon 1 mutations associate with an early-onset cognitive deficit subphenotype. Hum Mol Genet 11:12631271.
  • Genton P. (2007) International Workshop on Progressive Myoclonus Epilepsies. Sarlat, France.
  • Genton P, Gelisse P. (2000) Antimyoclonic effect of levetiracetam. Epileptic Disord 2:209212.
  • Genton P, Van Vleyman B. (2000) Piracetam and levetiracetam: Close structural similarities but different pharmacological and clinical profiles. Epileptic Disord 2:99105.
  • Genton P, Guerrini R, Remy C. (1999) Piracetam in the treatment of cortical myoclonus. Pharmacopsychiatry 32(Suppl 1):4953.
  • Genton P, Gelisse P, Thomas P, Dravet C. (2000) Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy? Neurology 55:11061109.
  • Genton P, Malafosse A, Moulard B, Rogel-Ortiz F, Dravet C, Bureau M, Roger J (2005). Progressive myoclonus epilepsies. In RogerJ, BureauM, DravetC, GentonP, TassinariCA, WolfP (Eds) Epileptic Syndromes in Infancy, Childhood and Adolescence. 4th ed. John Libbey Eurotext Ltd, Montrouge, France, pp. 441465.
  • Genton P, Gelisse P, Crespel A. (2006) Lack of efficacy and potential aggravation of myoclonus with lamotrigine in Unverricht-Lundborg disease. Epilepsia 47:20832085.
  • Grosso S, Orrico A, Galli L, Di Bartolo R, Sorrentino V, Balestri P. (2007) SCN1A mutation associated with atypical Panayiotopoulos syndrome. Neurology 69:609611.
  • Guerrini R, Belmonte A, Genton P. (1998a) Antiepileptic drug worsening of seizures in children. Epilepsia 39(Suppl 3):210.
  • Guerrini R, Dravet C, Genton P, Belmonte A, Kaminska A, Dulac O. (1998b) Lamotrigine and seizure aggravation in severe myoclonic epilepsy. Epilepsia 39:508512.
  • De Haan GJ, Halley DJ, Doelman JC, Geesink HH, Augustijn PB, Jager-Jongkind AD, Majoie M, Bader AJ, Leliefeld-Ten Doeschate LA, Deelen Wh, Bertram E, Lehesjoki AE, Lindhout D. (2004) Unverricht-Lundborg disease: underdiagnosed in the Netherlands. Epilepsia 45:10611063.
  • Harkin LA, McMahon JM, Iona X, Dibbens L, Pelekanos JT, Zuberi SM, Sadleir LG, Andermann E, Gill D, Farrell K, Connolly M, Stanley T, Harbord M, Andermann F, Wang J, Batish SD, Jones JG, Seltzer WK, Gardner A. (2007) The spectrum of SCN1A-reulated infantile epileptic encephalopathies. Brain 130:843852.
  • Hurd RW, Wilder BJ, Helveston WR, Uthman BM. (1996) Treatment of four siblings with progressive myoclonus epilepsy of the Univerricht-Lundborg type with N-acetylcysteine. Neurology 47:12641268.
  • Jansen FE, Sadleir LG, Harkin LA, Vadlamudi L, McMahon JM, Mulley JC, Scheffer IE, Berkovic SF. (2006) Severe myoclonic epilepsy of infancy (Dravet syndrome): recognition and diagnosis in adults. Neurology 67:22242226.
  • Joensuu T, Lehesjoki A-E, Kopra O. (2008) Molecular background of EPM1 – Univerricht-Lundborg disease. Epilepsia 49:557563.
  • Kalviainen R, Khyuppenen J, Koskenkorva P, Eriksson K, Vanninen R, Mervaala E. (2008) Clinical picture of EPM1-Unverricht-Lundborg disease. Epilepsia 49:549556.
  • Kanai K, Hirose S, Oguni H, Fukuma G, Shirasaka Y, Miyajima T, Wada K, Iwasa H, Yasumoto S, Matsuo M, Ito M, Mitsudome A, Kaneko S. (2004) Effect of localization of missense mutations in SCN1A on epilepsy phenotype severity. Neurology 63:329334.
  • Kananura C, Haug K, Sander T, Runge U, Gu W, Hallmann K, Rebstock J, Heils A, Steinlein OK. (2002) A splice-site mutation in GABRG2 associated with childhood absence epilepsy and febrile convulsions. Arch Neurol 59:11371141.
  • Kanazawa O. (1992) Medically intractable generalized tonic-clonic or clonic seizures in infancy. J Epilepsy 5:143148.
  • Kerem E. (2004) Pharmacologic therapy for stop mutations: how much CFTR activity is enough? Curr Opin Pulm Med 10:547552.
  • Korff CM, Nordli DR Jr. (2007) Diagnosis and management of nonconvulsive status epilepticus in children. Nat Clin Pract Neurol 3:505516.
  • Koskiniemi M, Van Vleymen B, Hakamies L, Lamusuo S, Taalas J. (1998) Piracetam relieves symptoms in progressive myoclonus epilepsy: A multicentre, randomized, double blind, crossover study comparing the efficacy and safety of three dosages of oral piracetam with placebo. J Neurol Neurosurg Psychiatry 64:334348.
  • Lafreniere RG, Rocheforg DL, Chretien N, Rommens JM, Cochius JI, Kalviainen R, Nousiainen U, Patry G, Farrell K, Soderfeldt B, Federico A, Hale BR, Cossio OH, Sorensen T, Pouliot MA, Kmiec T, Uldall P, Janszky J, Pranzatelli MR, Andermann F, Andermann E, Rouleau GA. (1997) Unstable insertion in the 5′ flanking region of the cystatin B gene is the most common mutation in progressive myoclonus epilepsy type 1, EPM1.. Nature Genet 15:298302.
  • Lalioti MD, Mirotsou M, Buresi C, Peitsch MC, Rossier C, Ouazzani R, Baldy-Moulinier M, Bottani A, Malafosse A, Antonarakis SE. (1997a) Identification of mutations in cystatin B, the gene responsible for the Unverricht-Lundborg type of progressive myoclonus epilepsy (EPM1). Am J Hum Genet 60:342351.
  • Lalioti MD, Scott HS, Buresi C, Rossier C, Bottani A, Morris MA, Malafosse A, Antonarakis SE. (1997b) Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy. Nature 386:847851.
  • Leiuallen K, Pennacchio LA, Park M, Myers RM, Lennon GG. (2001) Cystatin B-deficient mice have increased expression of apoptosis and glial activation genes. Hum Mol Genet 10:18671871.
  • Lopes-Cendes I, Scheffer IE, Berkovic SF, Rousseau M, Andermann E, Rouleau GA. (2000) A new locus for generalized epilepsy with febrile seizures plus maps to chromosome 2. Am J Hum Genet 66:698701.
  • Magaudda A, Gelisse P, Genton P. (2004) Antimyoclonic effect of levetiracetam in 13 patients with Unverricht-Lundborg disease: clinical observations. Epilepsia 45:678681.
  • Mantegazza M, Gambardella A, Rusconi R, Schiavon E, Annesi F, Cassulini RR, Labate A, Carrideo S, Chifari R, Canevini MP, Canger R, Franceschetti S, Annesi G, Wanke E, Quattrone A. (2005) Identification of an Nav1.1 sodium channel (SCN1A) loss-of-function mutation associated with familial simple febrile seizures. Proc Natl Acad Sci U S A 102:1817718182.
  • Marini C, Mei D, Temudo T, Ferrari AR, Buti D, Dravet C, Dias AI, Moreira A, Calado E, Seri S, Neville B, Narbona J, Reid E, Michelucci R, Sicca F, Cross HJ, Guerrini R. (2007) Idiopathic epilepsies with seizures precipitated by fever and SCN1A abnormalities. Epilepsia 48:16781685.
  • Medina MT, Martinez-Juarez IT, Duron RM, Genton P, Guerrini R, Dravet C, Bureau M, Perez-Gosiengfiao KT, Amador C, Bailey JN, Chaves-Sell F, Delgado-Escueta AV. (2005) Treatment of myoclonic epilepsies of childhood, adolescence, and adulthood. Adv Neurol 95:307323.
  • Moulard B, Guipponi M, Chaigne D, Mouthon D, Buresi C, Malafosse A. (1999) Identification of a new locus for generalized epilepsy with febrile seizures plus (GEFS+) on chromosome 2q24-q33. Am J Hum Genet 65:13961400.
  • Mulley JC, Scheffer IE, Petrou S, Dibbens LM, Berkovic SF, Harkin LA. (2005) SCN1A mutations and epilepsy. Hum Mutat 25:535542.
  • Nabbout R, Gennaro E, Dalla Bernardina B, Dulac O, Madia F, Bertini E, Capovilla G, Chiron C, Cristofori G, Elia M, Fontana E, Gaggero R, Granata T, Guerrini R, Loi M, La Selva L, Lispi ML, Matricardi A, Romeo A, Tzolas V, Valseriati D, Veggiotti P, Vigevano F, Vallee L, Dagna Bricarelli F, Bianchi A, Zara F. (2003) Spectrum of SCN1A mutations in severe myoclonic epilepsy of infancy. Neurology 60:19611967.
  • Nieto-Barrera M, Candau R, Nieto-Jimenez M, Correa A, Del Portal LR. (2000) Topiramate in the treatment of severe myoclonic epilepsy in infancy. Seizure 9:590594.
  • Ogino T, Ohtsuka Y, Yamatogi Y, Oka E, Ohtahara S. (1989) The epileptic syndrome sharing common characteristics during early childhood with severe myoclonic epilepsy of infancy. Jpn J Psychiatry Neurol 43:479481.
  • Oguni H, Hayashi K, Awaya Y, Fukuyama Y, Osawa M. (2001) Severe myoclonic epilepsy in infants – A review based on the Tokyo Women’s medical university series of 84 cases. Brain Develop 23:736748.
  • Oguni H, Hayashi K, Osawa M, Awaya Y, Fukuyama Y, Fukuma G, Hirose S, Mitsudome A, Kaneko S. (2005) Severe myoclonic epilepsy in infancy: Clinical analysis and relation to SCN1A mutations in a Japanese cohort. Adv Neurol 95:103117.
  • Ohki T, Watanabe K, Negoro K, Aso K, Haga Y, Kasai K, Kito M, Maeda N. (1997) Severe myoclonic epilepsy in infancy: evolution of seizures. Seizure 6:219224.
  • Ohmori I, Ouchida M, Ohtsuka Y, Oka E, Shimizu K. (2002) Significant correlation of the SCN1A mutations and severe myoclonic epilepsy in infancy. Biochem Biophys Res Commun 295:1723.
  • Ohmori I, Ohtsuka Y, Ouchida M, Ogino T, Maniwa S, Shimizu K, Oka E. (2003) Is phenotype difference in severe myoclonic epilepsy in infancy related to SCN1A mutations? Brain Dev 27:488493.
  • Osaka H, Ogiwara I, Mazaki E, Okamura N, Yamashita S, Iai M, Yamada M, Kurosawa K, Iwamoto H, Yasui-Furukori N, Kaneko S, Fujiwara T, Inoue Y, Yamakawa K. (2007) Patients with sodium channel alpha 1 gene mutation show wide phenotypic variation. Epilepsy Res 75:4651.
  • Peiffer A, Thompson J, Charlier C, Otterud B, Varvil T, Pappas C, Barnitz C, Gruenthal K, Kuhn R, Leppert M. (1999) A locus for febrile seizures (FEB3) maps to chromosome 2q23-24. Ann Neurol 46:671678.
  • Pennachio LA, Lehesjoki AE, Stone NE, Willour VL, Virtaneva K, Miao J, D’Amato E, Ramirez L, Faham M, Koskiniemi M, Warrington JA, Norio R, De La Chapelle A, Cox DR, Myers RM. (1996) Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 271:17311734.
  • Politano L, Nigro G, Nigro V, Piluso G, Papparella S, Paciello O, Comi LI. (2003) Gentamicin administration in Duchenne patients with premature stop codon. Preliminary results. Acta Myol 22:1521.
  • Ramalho AS, Beck S, Meyer M, Penque D, Cutting GR, Amaral MD. (2002) Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis. Am J Respir Cell Mol Biol 27:619627.
  • Rhodes TH, Vanoye CG, Ohmori I, Ogiwara I, Yamakawa K, George AL Jr. (2005) Sodium channel dysfunction in intractable childhood epilepsy with generalized tonic-clonic seizures. J Physiol 569:433445.
  • Scheffer IE, Berkovic SF. (1997) Generalized epilepsy with febrile seizures plus: A genetic disorder with heterogeneous clinical phenotypes. Brain 120:479490.
  • Seino M, Higashi T. (1978) The investigation on a group of secondary generalized epilepsy in childhood with onset in infancy and refractory grand mal. The Ministry of Health and Welfare – The foundation in commissioning investigation on psychosomatic disorders. The report of investigations in Showa 53, the group of investigation on children’s health and environment, pp. 7980.
  • Sermet-Gaudelus I, Renouil M, Fajac A, Bidou L, Parbaille B, Pierrot S, Davy N, Bismuth E, Reinert P, Lenoir G, Lesure JF, Rousset JP, Edelman A. (2007) In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: A pilot study. BMC Medicine 5:5.
  • Striano P, Coppola A, Pezzella M, Ciampa C, Specchio N, Ragona F, Mancardi MM, Gennaro E, Beccaria F, Capovilla G, Rasmini P, Besana D, Coppola GG, Elia M, Granata T, Vecchi M, Vigevano F, Viri M, Gaggero R, Striano S, Zara F. (2007) An open-label trial of levetiracetam in severe myoclonic epilepsy of infancy. Neurology 69:250254.
  • Tanaka M, Olsen RW, Medina MT, Schwartz E, Alonso ME, Duron RM, Castro-Ortega R, Martinez-Juarez IE, Pascual-Castroviejo I, Machado-Salas J, Silva R, Bailey JN, Bai D, Ochoa A, Jara-Prado A, Pineda G, Macdonald RL, Delgado Escueta AV. (2008). Hyperglycosylation and reduced GABA currents of mutated GABRB3 polypeptide in remitting childhood absence epilepsy. Am J Hum Genet 82:12491261.
  • Van Heycop Ten Ham MW. (1974) Lafora disease, a form of progressive myoclonus epilepsy. Handbook of Clinical Neurology 15:382422.
  • Wada T, Ishida T, Watanabe Y. (Eds) (1983): Epilepsy Atlas – CT and EEG. Igaku Shoin, Tokyo.
  • Wagner KR, Hamed S, Hadley DW, Gropman AL, Burstein AH, Escolar DM, Hoffman EP, Fischbeck KH. (2001) Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations. Ann Neurol 49:706711.
  • Wallace RH, Wang DW, Singh R, Scheffer IE, George AL Jr, Phillips HA, Saar K, Reis A, Johnson EW, Sutherland GR, Berkovic SF, Mulley JC. (1998) Febrile seizures and generalized epilepsy associated with a mutation in the Na+ channel β1 subunit gene SCN1B. Nat Genet 19:366370.
  • Wallace RH, Marini C, Petrou S, Harkin LA, Bowser DN, Panchal RG, Williams DA, Sutherland GR, Mulley JC, Scheffer IE, Berkovic SF. (2001a) Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures. Nat Genet 28:4952.
  • Wallace RH, Scheffer IE, Barnett S, Richards M, Dibbens L, Desai RR, Lerman-Sagie T, Lev D, Mazarib A, Brand N, Ben-Zeev B, Goikhman I, Singh R, Kremmidiotis G, Gardner A, Sutherland GR, George AL Jr, Mulley JC, Berkovic SF. (2001b) Neuronal sodium-channel α1-subunit mutations in generalized epilepsy with febrile seizures plus. Am J Hum Genet 68:859865.
  • Wallace RH, Hodgson BL, Grinton BE, Gardiner RM, Robinson R, Rodriquez-Casero V, Sadleir L, Morgan J, Harkin LA, Dibbens LM, Yamamoto T, Andermann E, Mulley JC, Berkovic SF, Scheffer IE. (2003) Sodium channel a1-subunit mutations in severe myoclonic epilepsy of infancy and infantile spasms. Neurology 61:765679.
  • Welch EM, Barton ER, Zhuo J, Tomizawa Y, Friesen WJ, Trifillis P, Paushkin S, Patel M, Trotta CR, Hwang S, Wilde RG, Karp G, Takasugi J, Chen G, Jones S, Ren H, Moon Y-C, Corson D, Turpoff AA, Campbell JA, Conn MM, Khan A, Almstead NG, Hedrick J, Mollin A, Risher N, Weetall M, Yeh S, Branstrom AA, Colacino JM, Babiak J, Ju WD, Hirawat S, Northcutt VJ, Miller LL, Spatrick P, He F, Kawana M, Feng H, Jacobson A, Peltz SW, Sweeney HL. (2007) PTC124 targets genetic disorders caused by nonsense mutations. Nature 447:8893.
  • Wilschanski M, Yahav Y, Yaacov Y, Balu H, Bentur L, Rivlin J, Aviram M, Bdolah-Abram T, Bebok Z, Shushi L, Kerem B, Kerem E. (2003) Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations. N Engl J Med 349:14331441.
  • Yakoub M, Dulac O, Jambaque I, Plouin P. (1992) Early diagnosis of severe myoclonic epilepsy in infancy. Brain Dev 14:299303.